Publications by authors named "Steven Ronkin"

Claim this Profile
D
Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1.
Michael J Boyd, Philip N Collier, Michael P Clark, Hongbo Deng, Sarathy Kesavan, Steven M Ronkin

J Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors.
Qing Tang, Alex M Aronov, David D Deininger, Simon Giroux, David J Lauffer, Steven Ronkin

ACS Med Chem Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates.
Pan Li, Warren Dorsch, David J Lauffer, Darius Bilimoria, Nathalie Chauret, Steven Ronkin

ACS Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles.
John J Court, Carl Poisson, Andrzej Ardzinski, Darius Bilimoria, Laval Chan, Steven Ronkin

J Med Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacy.
Emanuele Perola, Dean Stamos, Anne-Laure Grillot, Steven Ronkin, Tiansheng Wang

Bioorg Med Chem Lett· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
Steven M Ronkin, Michael Badia, Steve Bellon, Anne-Laure Grillot, Christian H Gross

Bioorg Med Chem Lett· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Paul S Charifson, Anne-Laure Grillot, Trudy H Grossman, Jonathan D Parsons, Michael Badia, Steven Ronkin

J Med Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis